180 related articles for article (PubMed ID: 8959062)
1. [Cutaneous and neurologic vasculitis disclosing EBV-selective immunodeficiency].
Grosieux C; Amoric JC; Mechinaud F; Moreau A; Mussini JM; Fesneau H; Dreno B; Bureau B; Stalder JF; Litoux P
Ann Dermatol Venereol; 1996; 123(6-7):387-92. PubMed ID: 8959062
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
Grierson HL; Skare J; Hawk J; Pauza M; Purtilo DT
Am J Med Genet; 1991 Sep; 40(3):294-7. PubMed ID: 1683154
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
[TBL] [Abstract][Full Text] [Related]
4. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.
Kanegane H; Ito Y; Ohshima K; Shichijo T; Tomimasu K; Nomura K; Futatani T; Sumazaki R; Miyawaki T
Am J Hematol; 2005 Feb; 78(2):130-3. PubMed ID: 15682426
[TBL] [Abstract][Full Text] [Related]
5. Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome.
Loeffel S; Chang CH; Heyn R; Harada S; Lipscomb H; Sinangil F; Volsky DJ; McClain K; Ochs H; Purtilo DT
Arch Pathol Lab Med; 1985 Jun; 109(6):546-50. PubMed ID: 2986573
[TBL] [Abstract][Full Text] [Related]
6. X-linked lymphoproliferative syndrome.
Sullivan JL; Woda BA
Immunodefic Rev; 1989; 1(4):325-47. PubMed ID: 2561059
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP).
Tatsumi E; Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S109-13. PubMed ID: 3030340
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated lymphoproliferative eruption with progression to large granular lymphocytic leukaemia.
Cho KH; Kim CW; Kwon OS; Yang SG; Park KC; Park MH; Cho HI; Kim JG
Br J Dermatol; 1997 Sep; 137(3):426-30. PubMed ID: 9349343
[TBL] [Abstract][Full Text] [Related]
9. Depression correlated with cellular immunity in systemic immunodeficient Epstein-Barr virus syndrome (SIDES).
Allen AD; Tilkian SM
J Clin Psychiatry; 1986 Mar; 47(3):133-5. PubMed ID: 3005245
[TBL] [Abstract][Full Text] [Related]
10. [Primary and isolated cutaneous lymphomatoid granulomatosis following heart-lung transplantation].
Tas S; Simonart T; Dargent J; Kentos A; Antoine M; Knoop C; Estenne M; De Dobbeleer G
Ann Dermatol Venereol; 2000 May; 127(5):488-91. PubMed ID: 10863178
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders.
Purtilo DT
Biomed Pharmacother; 1985; 39(2):52-8. PubMed ID: 2990590
[TBL] [Abstract][Full Text] [Related]
12. Immunodeficiency as a factor in lymphomagenesis.
Purtilo DT; Sakamoto K
Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
[TBL] [Abstract][Full Text] [Related]
13. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
Kammermeier-Schmidt U; Weiss M; Belohradsky BH
Monatsschr Kinderheilkd; 1993 Mar; 141(3):201-6. PubMed ID: 8386321
[TBL] [Abstract][Full Text] [Related]
14. HHV-8-related hemophagocytic lymphohistiocytosis in a boy with XLP phenotype.
Pasic S; Cupic M; Lazarevic I
J Pediatr Hematol Oncol; 2012 Aug; 34(6):467-71. PubMed ID: 22258354
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
[No Abstract] [Full Text] [Related]
16. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
17. Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses.
Miyawaki T
Iran J Allergy Asthma Immunol; 2004 Jun; 3(2):51-7. PubMed ID: 17301392
[TBL] [Abstract][Full Text] [Related]
18. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders.
Iwatsuki K; Ohtsuka M; Harada H; Han G; Kaneko F
Arch Dermatol; 1997 Sep; 133(9):1081-6. PubMed ID: 9301584
[TBL] [Abstract][Full Text] [Related]
20. Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent development of natural killer/T-cell lymphoma with angiodestruction.
Kanno H; Onodera H; Endo M; Maeda F; Chida S; Akasaka T; Sawai T
Hum Pathol; 2005 Feb; 36(2):212-8. PubMed ID: 15754300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]